Stocks · News reference
Evogene Ltd. announced its participation in an AI drug discovery roadshow on the U.S. East Coast, organized by the Israel Export Institute and TradeIL.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Under the terms of the Agreement, two current directors, Dr. Yael Margolin and Mr. Yoshinori Oikawa, who resigned from the Board will be replaced by Pure Capital Group nominees Dr. Adi Zuluf-Shani and Mr. Oz Adler.
Evogene (NASDAQ:EVGN) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.27) by 51.85 percent. This is a 74 percent increase over losses of $(0.50) per share from the same